Title:
４－（４－（１－イソプロピル－７－オキソ－１，４，６，７－テトラヒドロスピロ［インダゾール－５，４’－ピペリジン］－１’－カルボニル）－６－メトキシピリジン－２－イル）安息香酸の２－アミノ－２－（ヒドロキシメチル）プロパン－１，３－ジオール結晶塩
Document Type and Number:
Japanese Patent JP7237082
Kind Code:
B2
Abstract:
The invention provides the tris salt of 4-(4-(1-isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4′-piperidine]-1′-carbonyl)-6-methoxypyridin-2-yl)benzoic acid as a crystalline anhydrous or tri-hydrate; as well as polymorphs, pharmaceutical compositions, dosage forms, and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase (ACC) enzyme(s) in an animal.
Inventors:
Fernando, Dillini
La Casse, Sean M
Wiglesworth, Christine
La Casse, Sean M
Wiglesworth, Christine
Application Number:
JP2020545003A
Publication Date:
March 10, 2023
Filing Date:
November 14, 2018
Export Citation:
Assignee:
Pfizer Inc.
International Classes:
C07D471/10; A61K31/438; A61P1/16
Domestic Patent References:
| JP2013540119A |
Attorney, Agent or Firm:
Osamu Yamamoto
Toru Miyamae
Motoharu Nakanishi
Reiko Izumitani
Toru Miyamae
Motoharu Nakanishi
Reiko Izumitani
Previous Patent: 2-Methoxyethanol (MOE) reduction method
Next Patent: SUPPLY METHOD FOR AIR BLOW TO A PLURALITY OF LOADS AND DEVICE THEREFOR
Next Patent: SUPPLY METHOD FOR AIR BLOW TO A PLURALITY OF LOADS AND DEVICE THEREFOR